| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Signaling System | 7 | 2018 | 247 | 1.520 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2013 | 89 | 1.040 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 1070 | 1.010 |
Why?
|
| Cell Adhesion | 6 | 2018 | 324 | 0.950 |
Why?
|
| Alternative Splicing | 3 | 2013 | 93 | 0.910 |
Why?
|
| RNA-Binding Proteins | 3 | 2013 | 215 | 0.820 |
Why?
|
| Phosphorylation | 18 | 2019 | 1200 | 0.780 |
Why?
|
| Ovarian Neoplasms | 3 | 2013 | 267 | 0.780 |
Why?
|
| Neoplasms | 3 | 2019 | 1667 | 0.750 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2012 | 175 | 0.740 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 332 | 0.730 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 6 | 2016 | 150 | 0.710 |
Why?
|
| ras Proteins | 4 | 2018 | 102 | 0.700 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 23 | 0.650 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 5 | 2010 | 82 | 0.590 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2010 | 250 | 0.590 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 163 | 0.580 |
Why?
|
| Adenosine Triphosphate | 3 | 2010 | 314 | 0.560 |
Why?
|
| RNA Splice Sites | 2 | 2013 | 13 | 0.550 |
Why?
|
| Protein Engineering | 3 | 2010 | 35 | 0.460 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 22 | 0.460 |
Why?
|
| Signal Transduction | 6 | 2019 | 2689 | 0.440 |
Why?
|
| Cisplatin | 1 | 2013 | 192 | 0.430 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2013 | 195 | 0.430 |
Why?
|
| Cell Movement | 2 | 2019 | 630 | 0.390 |
Why?
|
| Amino Acid Sequence | 5 | 2012 | 1083 | 0.340 |
Why?
|
| Animals | 18 | 2019 | 20881 | 0.340 |
Why?
|
| Cell-Matrix Junctions | 1 | 2008 | 2 | 0.330 |
Why?
|
| RNA Splicing Factors | 3 | 2013 | 4 | 0.320 |
Why?
|
| COS Cells | 7 | 2011 | 155 | 0.310 |
Why?
|
| Cell Nucleus | 1 | 2008 | 305 | 0.290 |
Why?
|
| Cell Line | 5 | 2013 | 1752 | 0.270 |
Why?
|
| CDC2 Protein Kinase | 2 | 1995 | 13 | 0.250 |
Why?
|
| DNA Methylation | 2 | 2019 | 193 | 0.240 |
Why?
|
| Fibronectins | 4 | 2013 | 130 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2016 | 147 | 0.230 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 1851 | 0.230 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2002 | 8 | 0.210 |
Why?
|
| fas Receptor | 2 | 2013 | 54 | 0.210 |
Why?
|
| RNA Precursors | 2 | 2012 | 14 | 0.210 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2007 | 22 | 0.200 |
Why?
|
| Humans | 19 | 2019 | 68618 | 0.190 |
Why?
|
| ErbB Receptors | 2 | 2019 | 239 | 0.180 |
Why?
|
| Enzyme Activation | 7 | 2007 | 791 | 0.180 |
Why?
|
| Autophagy-Related Proteins | 1 | 2019 | 17 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 700 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2004 | 753 | 0.170 |
Why?
|
| Transfection | 3 | 2010 | 782 | 0.170 |
Why?
|
| Mutation | 5 | 2013 | 1213 | 0.170 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 34 | 0.170 |
Why?
|
| Binding Sites | 4 | 2004 | 631 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 78 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 742 | 0.150 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 170 | 0.150 |
Why?
|
| Autophagy | 1 | 2019 | 208 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 411 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2010 | 331 | 0.140 |
Why?
|
| p21-Activated Kinases | 4 | 2007 | 14 | 0.140 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 51 | 0.140 |
Why?
|
| Substrate Specificity | 3 | 2012 | 234 | 0.130 |
Why?
|
| Cell Cycle | 2 | 1995 | 312 | 0.130 |
Why?
|
| Maturation-Promoting Factor | 1 | 1995 | 1 | 0.130 |
Why?
|
| Protamine Kinase | 1 | 1995 | 3 | 0.130 |
Why?
|
| Protein Kinases | 2 | 2005 | 122 | 0.120 |
Why?
|
| Mice | 5 | 2019 | 8474 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1447 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2013 | 19 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 320 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 232 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 562 | 0.110 |
Why?
|
| Proteolysis | 1 | 2013 | 97 | 0.110 |
Why?
|
| Cortactin | 1 | 2013 | 3 | 0.110 |
Why?
|
| RGS Proteins | 1 | 2013 | 22 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.110 |
Why?
|
| Exons | 1 | 2013 | 122 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 69 | 0.110 |
Why?
|
| Gene Expression | 2 | 2013 | 770 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 304 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2012 | 17 | 0.100 |
Why?
|
| Histones | 1 | 2013 | 111 | 0.100 |
Why?
|
| STAT2 Transcription Factor | 1 | 2012 | 1 | 0.100 |
Why?
|
| Spliceosomes | 1 | 2012 | 2 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1293 | 0.100 |
Why?
|
| Cyclin D1 | 1 | 2012 | 37 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2010 | 272 | 0.100 |
Why?
|
| DNA Primers | 1 | 2012 | 302 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2012 | 237 | 0.100 |
Why?
|
| Receptor, ErbB-2 | 1 | 2012 | 129 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 120 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 384 | 0.100 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2008 | 27 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 284 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 139 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 201 | 0.090 |
Why?
|
| Base Sequence | 1 | 2012 | 1015 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2012 | 1174 | 0.090 |
Why?
|
| Thiazolidines | 1 | 2010 | 23 | 0.090 |
Why?
|
| Collodion | 1 | 2010 | 3 | 0.090 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2010 | 29 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 66 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1536 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2010 | 144 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 132 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 756 | 0.080 |
Why?
|
| Membranes, Artificial | 1 | 2010 | 88 | 0.080 |
Why?
|
| Apoptosis | 2 | 2013 | 1641 | 0.080 |
Why?
|
| Sphingolipids | 1 | 2012 | 337 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 77 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 2 | 2002 | 35 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1664 | 0.080 |
Why?
|
| Epidermal Growth Factor | 3 | 2004 | 95 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2673 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 204 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2004 | 6 | 0.070 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2004 | 14 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2550 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2008 | 682 | 0.070 |
Why?
|
| Female | 5 | 2019 | 38074 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 326 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 140 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 235 | 0.060 |
Why?
|
| Mink | 2 | 1995 | 12 | 0.060 |
Why?
|
| S Phase | 2 | 1995 | 38 | 0.060 |
Why?
|
| Epithelium | 2 | 1995 | 172 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 50 | 0.060 |
Why?
|
| Feedback | 1 | 2004 | 90 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 214 | 0.060 |
Why?
|
| Peptide Synthases | 1 | 2003 | 13 | 0.060 |
Why?
|
| Protein Binding | 2 | 2005 | 1027 | 0.050 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2003 | 7 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2003 | 165 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 122 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2002 | 89 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2003 | 112 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 1995 | 431 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 322 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 376 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 284 | 0.040 |
Why?
|
| Phagosomes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Lung | 2 | 1995 | 849 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 100 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2012 | 902 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 306 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 135 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 369 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 2791 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 2010 | 20 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2016 | 10 | 0.040 |
Why?
|
| Serine | 2 | 2007 | 99 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2016 | 95 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 509 | 0.030 |
Why?
|
| Mimosine | 1 | 1995 | 1 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 358 | 0.030 |
Why?
|
| G1 Phase | 1 | 1994 | 42 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 94 | 0.030 |
Why?
|
| Cell Division | 1 | 1994 | 541 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 92 | 0.030 |
Why?
|
| Kinetics | 1 | 1994 | 1047 | 0.030 |
Why?
|
| Kidney | 1 | 2016 | 945 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2012 | 525 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 7 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 137 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 1033 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 99 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 420 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 331 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 981 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2007 | 25 | 0.020 |
Why?
|
| Rats | 2 | 2007 | 5300 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 6 | 0.020 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2005 | 6 | 0.020 |
Why?
|
| Anilides | 1 | 2005 | 16 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 706 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2005 | 33 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 55 | 0.020 |
Why?
|
| Nitriles | 1 | 2005 | 68 | 0.020 |
Why?
|
| Androgen Antagonists | 1 | 2005 | 45 | 0.020 |
Why?
|
| Time Factors | 1 | 1994 | 4655 | 0.020 |
Why?
|
| Serum | 1 | 2005 | 24 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 134 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2005 | 138 | 0.020 |
Why?
|
| Cricetinae | 1 | 2005 | 262 | 0.020 |
Why?
|
| Transformation, Genetic | 1 | 2004 | 14 | 0.010 |
Why?
|
| Cell-Free System | 1 | 2004 | 43 | 0.010 |
Why?
|
| Isotope Labeling | 1 | 2004 | 30 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2005 | 215 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 2004 | 62 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 235 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2003 | 20 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2003 | 25 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2003 | 91 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 110 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 659 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 199 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2003 | 178 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 954 | 0.010 |
Why?
|
| Male | 2 | 2016 | 37321 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 778 | 0.010 |
Why?
|